LifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Rating of “Hold” by Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have earned an average recommendation of “Hold” from the five analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $8.70.

LFST has been the subject of a number of research reports. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a report on Monday, December 16th. Barclays raised their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. Finally, William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday.

Institutional Trading of LifeStance Health Group

A number of hedge funds have recently made changes to their positions in LFST. Forum Financial Management LP purchased a new position in LifeStance Health Group during the fourth quarter valued at approximately $110,000. Neo Ivy Capital Management grew its holdings in shares of LifeStance Health Group by 26,132.3% during the 4th quarter. Neo Ivy Capital Management now owns 182,052 shares of the company’s stock valued at $1,341,000 after acquiring an additional 181,358 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of LifeStance Health Group by 16.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 604,321 shares of the company’s stock worth $4,454,000 after acquiring an additional 87,502 shares during the last quarter. Vident Advisory LLC purchased a new stake in shares of LifeStance Health Group during the fourth quarter worth $156,000. Finally, Two Sigma Advisers LP acquired a new stake in LifeStance Health Group during the fourth quarter valued at $183,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST traded down $0.04 during trading hours on Friday, hitting $7.71. 871,111 shares of the company’s stock traded hands, compared to its average volume of 1,182,347. The company’s fifty day simple moving average is $7.79 and its two-hundred day simple moving average is $7.21. The company has a market cap of $2.95 billion, a price-to-earnings ratio of -29.75 and a beta of 1.28. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group has a 52 week low of $4.64 and a 52 week high of $9.00.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.